Tricuspid valve repair: durability and risk factors for failure.
By P. McCarthy, S. Bhudia, J. Rajeswaran, K. Hoercher, B. Lytle, D. Cosgrove, Eugene H. Blackstone. Journal of Thoracic and Cardiovascular Surgery, 2004
701 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/fbc7916fe484469b95932b20f4f26067853594f0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). (2012, neutral): “20–35% at 5 years.(179,180,185,186) Current experience favours the use of ring annuloplasty for severe TR related to isolated tricuspid annular dilatation.”
- Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (2006, background): “Better long-term results are observed with prosthetic rings than with the suture annuloplasty, the incidence of residual TR being, respectively, 10% vs 20–35% at 5 years [179, 180, 185, 186].”